These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 15379908

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of vitamin C supplementation in healthy dogs on antioxidative capacity and immune parameters.
    Hesta M, Ottermans C, Krammer-Lukas S, Zentek J, Hellweg P, Buyse J, Janssens GP.
    J Anim Physiol Anim Nutr (Berl); 2009 Feb; 93(1):26-34. PubMed ID: 19386005
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High-dose intravenous vitamin C is not associated with an increase of pro-oxidative biomarkers.
    Mühlhöfer A, Mrosek S, Schlegel B, Trommer W, Rozario F, Böhles H, Schremmer D, Zoller WG, Biesalski HK.
    Eur J Clin Nutr; 2004 Aug; 58(8):1151-8. PubMed ID: 15054428
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics in dogs after oral administration of two different forms of ascorbic acid.
    Wang S, Berge GE, Hoem NO, Sund RB.
    Res Vet Sci; 2001 Aug; 71(1):27-32. PubMed ID: 11666144
    [Abstract] [Full Text] [Related]

  • 9. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
    Slain D, Amsden JR, Khakoo RA, Fisher MA, Lalka D, Hobbs GR.
    Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasma profiles of lycopene after single oral and intravenous administrations in dogs.
    Vertzoni M, Valsami G, Reppas C.
    J Pharm Pharmacol; 2006 Sep; 58(9):1211-7. PubMed ID: 16945179
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
    Boothe DM, Perkins J.
    J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment.
    Weissinger EM, Nguyen-Khoa T, Fumeron C, Saltiel C, Walden M, Kaiser T, Mischak H, Drüeke TB, Lacour B, Massy ZA.
    Proteomics; 2006 Feb; 6(3):993-1000. PubMed ID: 16372263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.